Long Non-Coding RNAs ASB16-AS1 and AFAP1-AS1: Diagnostic, Prognostic Impact and Survival Analysis in Colorectal Cancer

Overview

Journal Appl Clin Genet

Publisher Dove Medical Press

Specialty Genetics

Date 2022 Aug 8

PMID 35937710

Authors

Naglaa S Elabd

Shimaa E Soliman

Moamena S Elhamouly

Suzy F Gohar

Ayman Elgamal

Mahmoud Magdy Alabassy

Haitham A Soliman

Abdelnaser A Gadallah

Osama D Elbahr

Ghada Soliman

Amany A Saleh

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to evaluate the diagnostic roles of AFAP1-AS1 and ASB16-AS1 in colorectal cancer and highlight their roles in predicting colorectal cancer patients' prognosis.

Methods: In this case-control study, 146 participants were involved. Group I included 47 patients with CRC. Group II composed of 49 patients with benign lesions in the colon, and Group III included 50 apparently normal subjects of coincided age and gender as controls. All participants were subjected to clinical and endoscopic evaluations, CA19-9, CEA, and quantification of relative expression of lncRNAs ASB16-AS1 and AFAP1-AS1.

Results: CRC patients had significantly elevated expression levels of both lncRNAs in tissue and plasma samples versus benign and control groups (p < 0.001). Despite the higher sensitivity of tissue samples results, the relative expression of both lncRNAs in plasma samples was very encouraging in the discrimination between patients with CRC versus control and benign groups. Furthermore, both lncRNAs could discriminate patients with early-stage CRC (stage I&II) from being colonic lesion and control groups with better sensitivity and specificity presented by ASB16-AS1 in tissue and plasma than results detailed by AFAP1-AS1. High expression levels of ASB16-AS1 in tissue and plasma and tissue lncRNA AFAP1-AS1 are significantly correlated with decreased overall survival (p < 0.001) and reduced progression-free (p < 0.001) compared to low expression in CRC patients.

Conclusion: We propose the utilization of lncRNA ASB16-AS1 and lncRNA AFAP1-AS1 as biomarkers in diagnosis and prognosis estimation for CRC patients. Moreover, their value in early CRC patients may affect the assortment of target therapy and treatment protocols.

Citing Articles

Assisting significance of lncRNA ASB16-AS1 in the early detection and prognosis prediction of patients with deep venous thrombosis.

Li M, Li Y, Zhang D, Cheng C, Yang M, Zhang X BMC Cardiovasc Disord. 2025; 25(1):89.

PMID: 39923021 PMC: 11806716. DOI: 10.1186/s12872-025-04487-0.

Long non‑coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review).

Lin Y, Zhao W, Pu R, Lv Z, Xie H, Li Y Oncol Lett. 2024; 28(4):486.

PMID: 39185489 PMC: 11342420. DOI: 10.3892/ol.2024.14619.

The functions and mechanisms of long non-coding RNA in colorectal cancer.

Lin Y, Zhao W, Lv Z, Xie H, Li Y, Zhang Z Front Oncol. 2024; 14:1419972.

PMID: 39026978 PMC: 11254705. DOI: 10.3389/fonc.2024.1419972.

Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.

Maekawa M, Tanaka A, Ogawa M, Roehrl M PLoS One. 2024; 19(5):e0302109.

PMID: 38696425 PMC: 11065211. DOI: 10.1371/journal.pone.0302109.

Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.

Jayawickrama S, Ranaweera P, Pradeep R, Jayasinghe Y, Senevirathna K, Hilmi A Cancer Rep (Hoboken). 2024; 7(3):e2045.

PMID: 38522008 PMC: 10961052. DOI: 10.1002/cnr2.2045.

References

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

Ding X, Duan H, Luo H . Identification of Core Gene Expression Signature and Key Pathways in Colorectal Cancer. Front Genet. 2020; 11:45. PMC: 7046836. DOI: 10.3389/fgene.2020.00045. View

Fang G, Ye B, Hu B, Ruan X, Shi Y . CircRNA_100290 promotes colorectal cancer progression through miR-516b-induced downregulation of FZD4 expression and Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2018; 504(1):184-189. DOI: 10.1016/j.bbrc.2018.08.152. View

Shi T, Gao G, Cao Y . Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics. Dis Markers. 2016; 2016:9085195. PMC: 4842029. DOI: 10.1155/2016/9085195. View

Pan F, Chen T, Sun X, Li K, Jiang X, Forsti A . Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles. Front Oncol. 2019; 9:252. PMC: 6465763. DOI: 10.3389/fonc.2019.00252. View

Saleh A, Kasem H, Zahran E, El-Hefnawy S . Cell-free long non-coding RNAs (LY86-AS1 & HCG27_201and GAS5) as biomarkers for pre-diabetes and type 2 DM in Egypt. Biochem Biophys Rep. 2020; 23:100770. PMC: 7267222. DOI: 10.1016/j.bbrep.2020.100770. View

Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J . Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013; 49(13):2949-59. DOI: 10.1016/j.ejca.2013.04.026. View

Liu F, Hu L, Pei Y, Zheng K, Wang W, Li S . Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis. BMC Cancer. 2020; 20(1):258. PMC: 7106910. DOI: 10.1186/s12885-020-6665-2. View

Yao Y, Chen X, Lu S, Zhou C, Xu G, Yan Z . Circulating Long Noncoding RNAs as Biomarkers for Predicting Head and Neck Squamous Cell Carcinoma. Cell Physiol Biochem. 2018; 50(4):1429-1440. DOI: 10.1159/000494605. View

10.

Tayel S, Fouda E, Gohar S, Elshayeb E, El-Sayed E, El-Kousy S . Potential role of MicroRNA 200c gene expression in assessment of colorectal cancer. Arch Biochem Biophys. 2018; 647:41-46. DOI: 10.1016/j.abb.2018.04.009. View

11.

Fang M, Zhang M, Wang Y, Wei F, Wu J, Mou X . Long Noncoding RNA AFAP1-AS1 Is a Critical Regulator of Nasopharyngeal Carcinoma Tumorigenicity. Front Oncol. 2020; 10:601055. PMC: 7719841. DOI: 10.3389/fonc.2020.601055. View

12.

Rawla P, Sunkara T, Barsouk A . Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019; 14(2):89-103. PMC: 6791134. DOI: 10.5114/pg.2018.81072. View

13.

Xiao C, Wu G, Zhou Z, Zhang X, Wang Y, Song G . RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer. Cell Death Dis. 2019; 10(11):833. PMC: 6828677. DOI: 10.1038/s41419-019-2070-7. View

14.

Han X, Wang L, Ning Y, Li S, Wang Z . Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer. Biol Res. 2016; 49(1):36. PMC: 5006422. DOI: 10.1186/s40659-016-0094-3. View

15.

Liu S, Iaria J, Simpson R, Zhu H . Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1. Cell Commun Signal. 2018; 16(1):10. PMC: 5850916. DOI: 10.1186/s12964-018-0223-4. View

16.

Yao X, You G, Zhou C, Zhang D . LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway. Cancer Manag Res. 2019; 11:9371-9378. PMC: 6847996. DOI: 10.2147/CMAR.S220434. View

17.

Marley A, Nan H . Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016; 7(3):105-114. PMC: 5069274. View

18.

Wong M, Huang J, Lok V, Wang J, Fung F, Ding H . Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location. Clin Gastroenterol Hepatol. 2020; 19(5):955-966.e61. DOI: 10.1016/j.cgh.2020.02.026. View

19.

Ma B, Hottiger M . Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation. Front Immunol. 2016; 7:378. PMC: 5031610. DOI: 10.3389/fimmu.2016.00378. View

20.

Arnold M, Sierra M, Laversanne M, Soerjomataram I, Jemal A, Bray F . Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016; 66(4):683-691. DOI: 10.1136/gutjnl-2015-310912. View